HKSE - Delayed Quote HKD

CKLIFE SCIENCES (0775.HK)

Compare
0.520
+0.025
+(5.05%)
At close: January 28 at 12:08:04 PM GMT+8

Key Executives

Amounts are as of December 31, 2023 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in HKD.
NameTitlePayExercisedYear Born
Mr. Tzar Kuoi Li B.Sc., LLD, LLD (Hon), M.Sc. Executive Chairman 125k -- 1964
Mr. Hing Lam Kam B.Sc., B.ScE, M.B.A. President & Executive Director 2.58M -- 1946
Mr. Edmond Tak Chuen IP B.A., M.Sc. Senior VP, Chief Investment Officer & Executive Director 1.6M -- 1952
Dr. Kean Meng Toh MBBS VP, Chief Scientific Officer & Executive Director 6.13M -- 1967
Mr. Lance Richard Lee Yuen VP, CEO & Executive Director -- -- 1965
Mr. Wun Lam Wong Chief Financial Officer -- -- 1965
Mr. Pak To Wu Chief Operating Officer of Global Operations -- -- 1962
Ms. Yau Lin Wong Senior Manager of Human Resources & Administration -- -- 1967
Ms. Ching Sze Chiu General Counsel -- -- 1977
Ms. Sze Mun Ho Vice President of Corporate Development -- -- 1972

CKLIFE SCIENCES

2 Dai Fu Street
Tai Po Industrial Estate
Tai Po
Hong Kong
852 2126 1212 https://www.ck-lifesciences.com
Sector: 
Healthcare
Industry: 
Biotechnology
Full Time Employees: 
1,968

Description

CK Life Sciences Int'l., (Holdings) Inc., an investment holding company, researches, develops, manufactures, commercializes, markets, and sells health and agriculture-related products in the Asia Pacific and North America. It manufactures and markets plant protection products and soluble fertilizers; manufactures, blends, distributes, and sells fertilizers, pesticides, and related agricultural products; manufactures and distributes horticultural products for the home gardening market; and produces non-sterile prescription and over-the-counter medicines. The company is also involved in the contract manufacturing of complementary healthcare medicines, pharmaceutical products, and cosmetics; licensing of registration activities and the importation of finished agricultural goods; holding of land and buildings; financing activities; investment in financial instruments and vineyards; trading of biotechnology products and nutritional supplements; and manufacturing, wholesaling, retailing, and distribution of nutraceutical products. In addition, it distributes turf management machinery, hardware, equipment, and accessories, as well as turf fertilizers, chemicals, and professional pest products; produces, refines, and distributes salt products; and provides research and development services for biotechnology and life sciences technology products. Further, it researches, develops, manufactures, and commercializes drug products to treat pain and melanoma; supplies raw materials for nutritional health, pharmaceutical, cosmetics, personal care, and food segments; and offers packing and asset management services. The company was founded in 1999 and is headquartered in Tai Po, Hong Kong.

Corporate Governance

CKLIFE SCIENCES’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.

Upcoming Events

Recent Events

May 23, 2023 at 12:00 AM UTC

Ex-Dividend Date

Related Tickers